In Veritas Medical Diagnostics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVME research report →
Company
In Veritas Medical Diagnostics, Inc. , a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke.
- CEO
- G. T. Cooper
- IPO
- 2004
- Employees
- 7
- HQ
- Inverness, GB
Price Chart
Valuation
- Market Cap
- $60.23K
- P/E
- -0.39
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- -34.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 1.86%
- ROIC
- 3.23%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-107,800 · 0.00%
- EPS
- $-0.00 · 0.00%
- Op Income
- $-107,800
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.30
- 52W Low
- $0.00
- 50D MA
- $0.19
- 200D MA
- $0.10
- Beta
- 7.80
- Avg Volume
- 5
Get TickerSpark's AI analysis on IVME
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IVME Coverage
We haven't published any research on IVME yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IVME Report →